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in the acute stage?
Lorenz Ertl1,2*†, Dominik Morhard1†, Maria Deckert-Schmitz3, Jennifer Linn2 and Gernot Schulte-Altedorneburg1Abstract
Background: Acute non-traumatic focal subarachnoid haemorrhage (fSAH) is a rare transient ischaemic attack
(TIA)-mimic. MRI is considered to be indispensable by some authors in order to avoid misdiagnosis, and subsequent
improper therapy. We therefore evaluated the role of CT and MRI in the diagnosis of fSAH patients by comparing
our cases to those from the literature.
Methods: From 01/2010 to 12/2012 we retrospectively identified seven patients with transient neurological episodes
due to fSAH, who had received unenhanced thin-sliced multiplanar CT and subsequent MRI within 3 days on a 1.5 T
scanner. MRI protocol included at least fast-field-echo (FFE), diffusion-weighted imaging (DWI), T2-weighted
fluid-attenuated inversion recovery (FLAIR) and time-of-flight (TOF) MRA sequences. By using MRI as gold-standard,
we re-evaluated images and data from recent publications regarding the sensitivity to detect fSAH in unenhanced CT.
Results: fSAH was detected by CT and by FFE and FLAIR on MRI in all of our own cases. However, DWI and T2w-spin-
echo sequences revealed fSAH in 3 of 7 and 4 of 6 cases respectively. Vascular imaging was negative in all cases.
FFE-MRI revealed additional multiple microbleeds and superficial siderosis in 4 of 7 patients and 5 of 7 patients
respectively. Including data from recently published literature CT scans delivered positive results for fSAH in 95 of
100 cases (95%), whereas MRI was positive for fSAH in 69 of 69 cases (100%).
Conclusions: Thin-sliced unenhanced CT is a valuable emergency diagnostic tool to rule out intracranial
haemorrhage including fSAH in patients with acute transient neurological episodes if immediate MRI is not
available. However, MRI work-up is crucial and mandatorily has to be completed within the next 24–72 hours.
Keywords: Transient ischaemic attack, Subarachnoid haemorrhage, Computed tomography, Magnetic resonance
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Diagnosis of transient ischemic attack (TIA) and differenti-
ation from TIA-mimics is challenging, since misdiagnosis
may lead to inappropriate treatment. Recent trials on TIA
patients have shown that clinical scores are of limited
use in identifying individuals at risk if neuroimaging is
not considered [1].* Correspondence: lorenz.ertl@med.uni-muenchen.de
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unless otherwise stated.Several authors have reported a rare but important
migraine-like TIA-mimic syndrome consisting of mi-
gratory, crescendo-like, somatosensory symptoms with
a spontaneous focal subarachnoid haemorrhage (fSAH)
of the contralateral cerebral hemisphere [2-8]. Neuro-
imaging reveals a characteristic pattern of fSAH, mostly
in the corresponding pre- or postcentral sulcus.
There is still no standardised diagnostic work-up for
fSAH patients, but such a work-up is of great importance,
since therapy schemes of acute intracranial haemorrhage
and cerebral ischemia differ substantially. Many authors
recommend MRI as the first-choice technique to detect
fSAH, since CT is suspected to be insensitive to circum-
scribed subarachnoid haemorrhage [2,3,5,9]. This statement. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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neurological department participating in TIA care without
providing MRI on a 24/7 basis.
In this study, neuroradiological and clinical data of
seven of our own patients with fSAH are presented to
evaluate the role of CT in comparison to MRI as a primary
diagnostic tool. We compared our imaging findings to
previously published cases of fSAH.
Methods
Subjects
Our institution provides an accredited stroke unit on a
24/7 basis and a TIA outpatient clinic from 8 a.m. to 5 p.
m. on weekdays. Standard diagnostic work-up of patients
presenting at our hospital with transient neurological
episodes is as follows. During the opening hours of our
TIA outpatient clinic, immediate MRI examination includ-
ing FLAIR, DWI, FFE and TOF-MRA sequences is done. If
MRI is not available, an unenhanced cranial CT scan and
an ultrasound examination of the extra- and intracranial
brain-supplying arteries is performed. MRI work-up is com-
pleted as soon as possible within 24–72 hours.
Patients were identified by a retrospective query on all
cranial MRI examination reports (n = 7482) in the radio-
logical database of our institution between 01/2010 and
12/2012. The following search terms were used: “siderosis”,
“subarachnoid hemorrhage”, “focal SAH”. The primary
search yielded 243 patients. Patients were included if they
fulfilled the following criteria: 1.) presence of a focal SAH at
the cerebral convexity, defined as a linear hyperintensity on
FLAIR-images and linear hypointensity in T2*-images in
MRI; 2.) patients had received an unenhanced CT scan of
the brain prior to the MRI.
Patients were excluded if they had obvious causes of
bleeding such as 1.) aneurysmal SAH or SAH from other
intracranial vascular malformations (n = 45), 2.) traumatic
SAH (n = 45), 3.) primary intracerebral bleeding or haem-
orrhagic brain tumor with extension to the subarachnoid
space (n = 25), 4.) derailment of blood coagulation (n = 3).
Finally, we identified seven patients with non-traumatic
fSAH during this three year period who met the inclusion
and exclusion criteria (Table 1).
After identification of the patients, demographic and
clinical characteristics and the final diagnosis were re-
trieved from hospital records (Table 1). An experienced
stroke neurologist (M.S.-D.) verified all clinical symptoms
and diagnoses, including clinical history, electroenceph-
alogram (EEG), electrocardiogram, echocardiography and
routine blood tests.
MR imaging
All MRI examinations were performed on a 1.5 T scan-
ner (Intera, 1.5 T, Philips GmbH-Healthcare, Hamburg,
Germany). In all cases imaging protocol included fast-field-echo (FFE), diffusion-weighted imaging (DWI), T2-
weighted fluid-attenuated inversion recovery (FLAIR),
T2-weighted spin-echo sequence, and time-of-flight MR
angiography (TOF-MRA) of the intracranial arteries.
In five patients, T1-weighted unenhanced and contrast-
enhanced (0.1 mmol Gd-DTPA per kg body weight)
scans were acquired (pat. 1, 2, 3, 6, 7). Phase-contrast
(PC)-MRA of the cerebral veins and sinuses was obtained
in six patients (pat. 1, 2, 4–7). Microbleeds (MB) were
identified and differentiated from intracerebral haemor-
rhage according to Greenberg et al. [10]. Superficial side-
rosis (SS) was defined as linear blood residues in several
superficial cortical layers of the brain on FFE images.
fSAH was differentiated from SS, when it was an isolated
finding in a neuroanatomical location corresponding to
the TIA-like symptoms.Computed tomography
Axial multislice CT scans were obtained on a 16-slice or
a dual-source 2x128-slice scanner (Somatom Sensation
16 and Definition FLASH, both Siemens Healthcare,
Forchheim, Germany) in helical-scan mode using 0.6-
0.75 mm collimation. Two sets of reconstructions with
0.75/0.5 mm and 4.5-9/3-5 mm (slice-thickness/increment)
were calculated. The detailed protocols of CT scanning and
multiplanar reconstructions, including reconstruction inter-
val, collimation and slice thickness, are given in Figure 1.Additional vascular imaging
All patients underwent extracranial cervical doppler
sonography. Conventional four-vessel angiography was
performed in two patients (patients 1 and 3), whereas
cervical contrast enhanced MRA was available in two
cases (patients 1 and 7). Patient 4 underwent intra- &
extracranial CTA.Image analysis
Neuroradiological images were re-evaluated by three
experienced neuroradiologists (L.E., D.M., G.S.-D.). Prior
to the reading process, all individual patient data in the
images were replaced by a pseudonomized numeric code.
CT and MR images were evaluated in a randomised order.
Thus, readers were blinded to the individual CT and MR
examinations as well as to the clinical history. After the
individual reading process, the participating radiologists
met for a consensus reading, leading to a common inter-
pretation of the imaging material. Venous and arterial
MRA, CTA and conventional angiographies were also
re-analysed with special regard to vascular malformations,
vasculitides and cortical vein thrombosis. Due to the
retrospective study design, institutional review board
approval was not needed.












fSAH positive SS MB
1 Left-sided sensory deficits >1 (5–15 min) Right precentral <24 h / <24 h Yes FLAIR, FFE, T1w+/−Gd None None Normal
2 Aphasia, numbness
(right upper extremity)




>1 (10–30 min) Left central <24 h / <48 h Yes FLAIR,FFE, T1w+/−Gd Front partial & pontine 12 Alpha pattern (8/s)
delta decelerations left
parietotemporal
4 Left-sided paraesthesia >1 (5–10 min) Right central 2d /5d Yes FLAIR,FFE, T2w,T1w Bilateral frontal 18 Normal
5 Vertigo, fluctuating left-sided
sensomotory deficit
4 (10-30 min) Right central <24 h / <48 h Yes FLAIR,FFE, T2w,DWI, T1w+/−Gd None >20 n.a.
6 Acute cognitive deficits, mild
right-sided hypaesthesia
>1 (5–10 min) Left precentral <24 h / <48 h Yes FLAIR,FFE, T2w,T1w + Gd Bilateral frontoparietal >30 Slowed baseline activity,
intermittent generalized
decelerations



















Figure 1 Physical acquisition parameters of CT scanner.
Ertl et al. BMC Neurology 2014, 14:80 Page 4 of 6
http://www.biomedcentral.com/1471-2377/14/80Literature search strategy
Articles were identified in the PubMed-Medline database
up to December 2013. The following key words were used
for the search: “focal/non traumatic/cortical subarachnoid
haemorrhage”, “transient ischaemic attack”, “microbleeds”,
“cerebral amyloid angiopathy”, “crescendo aura attacks”
(limits were English and humans).
Publications were selected if they reported on radio-
logical and clinical characteristics of fSAH including CT




fSAH was detectable in primary unenhanced CT scan
in all of 7 cases. Clinical and radiological characteristics
are given in Table 1. All patients (5 female, 2 male) were
older than 67 years and suffered predominantly from sen-
sory deficits. In 6 of 7 patients, the delay between the last
episode and the CT examination was < 24 hours. In none
of the cases vascular imaging revealed a stenosis of > 50%
lumen reduction or showed evidence for vasculitis, RCVS
or any other vascular malformation. All patients were
discharged without recurrence of symptoms.
Literature research
Eight case series were identified with a total of 102
patients, including our own data (Table 2). 100 of 102
patients underwent an unenhanced CT scan that delivered
positive results for fSAH in 95 cases (95%). MRI wasavailable in 97 of 102 patients. 28 of those were found in a
publication in which the exact number of positive findings
for fSAH in MRI was not provided [8]. They were thus
excluded, resulting in a total of 69 MRI examinations,
of which 69 were positive for fSAH (100%).
Discussion
During a three-year period, we detected seven cases of
TIA-mimicking non-traumatic fSAH in a study popula-
tion of subjects who had received unenhanced CT and
MR imaging work-up. fSAH was detectable in both mo-
dalities in all of the cases. This is in line with previously
published cases from the literature (Table 2).
The clinical symptoms and radiological appearance of
fSAH differ completely from those of SAH following the
rupture of an aneurysm or non-aneurysmal perimesen-
cephalic SAH [2,3,5,9]. Patients experience recurrent,
transient, spreading somatosensory deficits lasting a few
to several minutes. An associated headache is usually
not found in elderly patients [8].
Several aetiologies have been found to be associated
with fSAH [8,11]. According to Kumar, the most probable
cause of fSAH in patients older than 60 years is cerebral
amyloid angiopathy (CAA), while reversible cerebral vaso-
constriction syndrome (RCVS) is the most common aeti-
ology in patients younger than 60 years [8]. Geraldes et al.
found large artery atherosclerosis to be the most probable
underlying cause in one third of fSAH patients [11].
Similar to Raposo et al. [5], we found preexisting multi-
focal haemorrhagic lesions (MB and/or SS) in 4 of seven
Table 2 fSAH in recent literature compared with own data
Ref. no. Number of patients Mean age (range) CT positive for fSAH MRI positive for fSAH Percentage [Pos CT/Pos MRI]
[2] 7 74 (63–82) 5/7 7/7 70%
[3] 4 78 (68–85) 4/4 4/4 100%
[4] 2 74 (73–74) n.a. 2/2 -
[5] 10 74 (62–87) 10/10 10/10 100%
[6] 2 76 (70–81) 2/2 2/2 100%
[7] 24 70 (37–88) 24/24 20/20 -
[8] 29 58 (29–87) 28/29 n.a./28 -
[15] 17 78 (69–96) 15/17 17/17 88%
Own data 7 79 (68– 84) 7/7 7/7 100%
Total 102 - 95/100 (95%) 69/69(100%) -
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patients were significantly older than patients with the
common causes of SAH (i.e. traumatic, aneurysmal).
In the AHA/ASA Scientific Statement, MRI is recom-
mended as superior to CT for managing TIA [12]. In previ-
ous TIA studies, however, MRI was frequently the first-line
imaging in less than 30%-50% of TIA patients [12], since
MRI cannot be tolerated or is contraindicated in ~10% of
patients, and 24/7 availability is sometimes not given even
in many neurovascular centers.
One of the most difficult problems that clinicians face in
patients with transient neurological deficits, is to avoid
misdiagnosis of intracranial haemorrhage as a classical
TIA and subsequent mistreatment with antiplatelets or
anticoagulants. While early antithrombotic therapy is
beneficial in patients with TIA, AHA Stroke Council
guidelines recommend “individual assessment of each case”
in TIA patients with suspected ICH [13]. The authors cite
a “paucity of data from large, prospective, randomized
studies” to answer this important management question
and emphasize the small number of case series addressing
SAH as a potential cause of a TIA-mimic [13].
Currently, there is no standardised MRI protocol in TIA
patients. Previous studies showing superiority of MRI in
TIA patients reported only on the diagnostic value of
DWI [12]. However, detection of SAH requires an appro-
priate MRI protocol that goes beyond the “fast DWI
protocol” for stroke and TIA patients. FLAIR sequence is
very sensitive to pathologies of the subarachnoid space,
but not specific for SAH [14]. GRE or susceptibility-
weighted sequences are very sensitive to haemosiderin
and therefore important for the diagnosis of fSAH. How-
ever, GRE images do not allow differentiation between
acute haemorrhage and residual posthaemorrhagic hae-
mosiderin deposits.
Unenhanced CT scans allowed detection of fSAH in all
our patients. In accordance with our results, a review of the
literature for fSAH revealed that the initial unenhanced CT
scan was positive in 95 of 100 cases (95%) (Table 2).Brunot and co-workers [2] reported 2 of 7 fSAH patients
presenting with negative initial CT scans prior to MRI.
The authors concluded that fSAH were not systematically
detectable by unenhanced CT scans [2]. However, in these
two cases, negative CT scans were acquired immediately
after the first of several recurrent transient neurological
episodes. MRI was performed 3–4 weeks later and after at
least one more neurological event [2]. Besides that exact
CT acquisition parameters such as collimation were not
provided.
Similar to this 2 out of 17 CT scans were negative
for fSAH compared to MRI in the series of Apoil
et al., but also in this publication no detailed informa-
tion on timing and physical acquisition parameters of
the CT examination was given [15].
The discrepancy between our results and those in the
literature might reflect differences in timing and choice
of investigations, which indeed is a notable aspect and
might limit our findings. We strongly recommend careful
analysis of thin-sliced multiplanar primary reconstruc-
tion CT images (ST 0.75 mm/RI 0.5 mm) to enhance
investigator-dependent sensitivity for fSAH, and com-
pletion of MRI work-up within 3 days.
Other authors also recommended MRI as the first
choice for diagnosis of fSAH, although they reported a
100% rate of CT in detecting fSAH (Table 2) [3,5,9].
Unfortunately, a detailed comparison of the diagnostic
accuracy of CT and MRI was not available in the case
series of Kumar et al. [8].
According to our data, careful analysis of multiplanar
thin-sliced CT allows for detection of acute fSAH with
sufficient diagnostic power in an emergency setting. How-
ever, despite its appropriateness as a readily available
primary diagnostic tool, CT does not provide import-
ant additional information about other manifestations
of cerebral small vessel diseases, including micro-
bleeds, siderosis, ischaemic brain injury and newer
small vessel disease markers. We thus emphasize the
need for an extensive secondary MRI work-up which
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risk of ICH [16].
The small number of cases acquired and the retrospect-
ive design of our study limits general recommendations
from our data and does not allow a statistically valuable
sensitivity/specificity analysis, as in previously published
works [2,3,5,9,15]. Due to the short period between
clinical onset and CT examination, we might have not
missed one of the fSAH in CT. Unlike previous studies,
our patients (except pat. no. 4) suffered from an acute
transient focal neurological episode within 24 hours
prior to the CT. In patients, whose last neurological
episode dates back more than 48 hour, MRI should be
preferred as primary diagnostic tool. Nevertheless, our
data as well as the reported data from the literature
might encourage stroke-neurologists as well as neuroradi-
ologists to regard CT as a valuable diagnostic tool which
allows for recognising even fSAH in TIA-patients with a
quite high accuracy in an emergency setting.
Conclusion
Unenhanced CT is a valuable emergency diagnostic tool
to rule out acute intracranial haemorrhage including
fSAH in patients with transient neurological episodes if
immediate MRI is not available. However, we emphasize
that a single unenhanced CT scan cannot be considered
sufficient to investigate transient neurological episodes
and to guide antithrombotic use on its own. MRI work-up
is indispensable for the further detection of SS, MB, and
other parenchymal abnormalities and has to be completed
within the next 24–72 hours. It should contain at least
FLAIR, DWI, FFE and TOF-MRA sequences. Non-invasive
vascular imaging is helpful to exclude potential associated,
coincidental and additional pathologies. Catheter angiog-
raphy is then usually expendable.
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